Thinkhat
At Thinkhat, we are building platforms that transform innovative concepts into successful companies through ideation, incubation, and illumination. Leveraging artificial intelligence and machine learning (AI/ML), opportune investments, and strategic partnerships, we are unlocking new possibilities across the continuum of life sciences (upstream) and healthcare (downstream). In the past 24 months, we have established robust healthcare and life sciences platforms, laying a solid foundation with a global team of over 120 specialists: scientists, researchers, machine learning engineers, strategists, full-stack developers, and UI/UX designers. Our 2024 portfolio (Cohort 1) includes over 10 initiatives addressing critical issues, such as Operational inefficiencies in health systems Alleviating physician burnout and administrative burdens Creating sequence-as-a-service solutions for targeted diseases Advancing personalized precision medicine Conducting R&D in CRISPR and mRNA for novel cell and gene therapies To learn more, visit www.thinkhat.ai.
Thinkhat
At Thinkhat, we are building platforms that transform innovative concepts into successful companies through ideation, incubation, and illumination. Leveraging artificial intelligence and machine learning (AI/ML), opportune investments, and strategic partnerships, we are unlocking new possibilities across the continuum of life sciences (upstream) and healthcare (downstream). In the past 24 months, we have established robust healthcare and life sciences platforms, laying a solid foundation with a global team of over 120 specialists: scientists, researchers, machine learning engineers, strategists, full-stack developers, and UI/UX designers. Our 2024 portfolio (Cohort 1) includes over 10 initiatives addressing critical issues, such as Operational inefficiencies in health systems Alleviating physician burnout and administrative burdens Creating sequence-as-a-service solutions for targeted diseases Advancing personalized precision medicine Conducting R&D in CRISPR and mRNA for novel cell and gene therapies To learn more, visit www.thinkhat.ai.
TL;DR
What they do: AI/ML venture studio building and incubating startups in healthcare and life sciences
Headquarters & hubs: San Juan, Puerto Rico (HQ); hubs in Boston and San Francisco
Team size: ≈110–120 specialists
Portfolio / initiatives: 11–12 HLS initiatives; examples include Renue Life Sciences, nCode, Noki, Cherish, Enliv Health
Capital deployed (studio): $20M+ reported capital invested across initiatives